Canada markets closed

Viracta Therapeutics, Inc. (VIRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.8102-0.0298 (-3.55%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 31.82M
Enterprise Value 9.14M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.47
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.19

Trading Information

Stock Price History

Beta (5Y Monthly) 0.36
52-Week Change 3-5.62%
S&P500 52-Week Change 322.38%
52 Week High 32.3800
52 Week Low 30.4300
50-Day Moving Average 30.9370
200-Day Moving Average 30.8806

Share Statistics

Avg Vol (3 month) 3114.84k
Avg Vol (10 day) 348.68k
Shares Outstanding 539.27M
Implied Shares Outstanding 640.72M
Float 824.55M
% Held by Insiders 12.76%
% Held by Institutions 152.79%
Shares Short (Apr 15, 2024) 4686.73k
Short Ratio (Apr 15, 2024) 44.96
Short % of Float (Apr 15, 2024) 42.22%
Short % of Shares Outstanding (Apr 15, 2024) 41.75%
Shares Short (prior month Mar 15, 2024) 4634.26k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Sept 03, 2020
Ex-Dividend Date 4N/A
Last Split Factor 2285:1000
Last Split Date 3Feb 25, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-41.50%
Return on Equity (ttm)-128.57%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -50.2M
Net Income Avi to Common (ttm)-51.06M
Diluted EPS (ttm)-1.3200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)53.83M
Total Cash Per Share (mrq)1.37
Total Debt (mrq)25.56M
Total Debt/Equity (mrq)139.51%
Current Ratio (mrq)1.43
Book Value Per Share (mrq)0.33

Cash Flow Statement

Operating Cash Flow (ttm)-39.89M
Levered Free Cash Flow (ttm)-21.79M